Devyser Diagnostics AB publishes year-end report for January to December 2023
“Devyser is able to report strong sales growth and record high gross margins for the fourth...
“Devyser is able to report strong sales growth and record high gross margins for the fourth...
Devyser Genomic Laboratories, Devyser's US-based CLIA-certified laboratory, has signed its first...
Devyser has been awarded a tender for Devyser’s CFTR fragment analysis products, that are used for...
Devyser Diagnostics AB has entered an in vitro diagnostic development agreement with Illumina, Inc....
Devyser has been awarded a tender for Devyser’s CFTR fragment analysis products, that are used for...
Devyser has been awarded a tender for Devyser RHD, its product for non-invasive fetal RHD status in...
“Devyser is reporting record sales growth (+50% organic growth) for the third quarter, a further...
Dear Devyser network, partners, and valued customers,
Devyser and Thermo Fisher Scientific have entered into a collaboration agreement to promote...
Devyser and Thermo Fisher Scientific have agreed to expand commercial collaboration by including...
Devyser’s novel test for detecting donor-derived cell-free DNA in blood samples from...